Medication info
Rabiet Duo Tablet 20/500 mg

Rabiet Duo Tablet 20/500 mg

Prescription medicationTabletOral
Ingredient · strength
Sodium Bicarbonate›500mg / 1 tabletRabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
Yellow-brown, egg-shaped film-coated tablets
Packaging
28 tablets/bottle
Approval status
Active

MFDS item code 202200474 · Approved 2022.01.27 · Insurance code 642906640

Summary

Main use
Treatment, symptom relief, and maintenance therapy for gastroesophageal reflux disease; treatment of gastric and duodenal ulcers
Who takes it
Adults · Children
Adult dose
Although this medicine contains 10 mg and 20 mg of rabeprazole sodium in the 10/500mg and 20/500mg strengths, respectively, note that the amount of sodium bicarbonate in 2 tablets of 10/500mg is not the same as that in 1 tablet of 20/500mg. 1) Gastric ulcer and duodenal ulcer: The usual adult dose is 10/500mg orally once daily. Depending on symptoms, 20/500mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. 2) Erosive or ulcerative gastroesophageal reflux disease: Administer 10/500mg or 20/500mg once daily for 4∼8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10/500mg or 20/500mg may be administered orally twice daily for an additional 8 weeks. However, 20/500mg twice daily is restricted to patients with confirmed severe mucosal damage. 3) Relief of symptoms of gastroesophageal reflux disease: Administer 10/500mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, if needed, using on-demand therapy with 10/500mg once daily. 4) Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10/500mg or 20/500mg orally once daily, depending on the patient. Patients with hepatic impairment: Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Elderly patients: Use with caution because liver function is often impaired.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment, symptom relief, and maintenance therapy for gastroesophageal reflux disease; treatment of gastric and duodenal ulcers

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
View approved original text

This medication is used to treat gastric ulcer and duodenal ulcer. It also helps in the treatment of erosive or ulcerative gastroesophageal reflux disease. It alleviates symptoms caused by gastroesophageal reflux disease, reducing discomfort for patients. It can also be used for long-term maintenance therapy, effectively preventing recurrence. Overall, it is used in the treatment of ulcers and gastroesophageal reflux disease in the gastrointestinal tract.

How to take

Adult dose

Although this medicine contains 10 mg and 20 mg of rabeprazole sodium in the 10/500mg and 20/500mg strengths, respectively, note that the amount of sodium bicarbonate in 2 tablets of 10/500mg is not the same as that in 1 tablet of 20/500mg. 1) Gastric ulcer and duodenal ulcer: The usual adult dose is 10/500mg orally once daily. Depending on symptoms, 20/500mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. 2) Erosive or ulcerative gastroesophageal reflux disease: Administer 10/500mg or 20/500mg once daily for 4∼8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10/500mg or 20/500mg may be administered orally twice daily for an additional 8 weeks. However, 20/500mg twice daily is restricted to patients with confirmed severe mucosal damage. 3) Relief of symptoms of gastroesophageal reflux disease: Administer 10/500mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, if needed, using on-demand therapy with 10/500mg once daily. 4) Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10/500mg or 20/500mg orally once daily, depending on the patient. Patients with hepatic impairment: Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Elderly patients: Use with caution because liver function is often impaired.

Child dose

Safety in children has not been established.

Precautions

This medication should not be administered to certain patients. First, it must not be given to patients with allergies or a history of hypersensitivity to this drug or its ingredients. Second, this medication should not be used in patients taking atazanavir. Third, pregnant women or nursing mothers should not take this medication. Fourth, it must not be administered to patients taking rilpivirine. This medication should be used cautiously in some patients. Patients with impaired liver function, elderly patients, those with a history of drug allergies, patients with severe gastrointestinal ulcers, patients with impaired kidney function, patients with weak heart or lung function, and patients with electrolyte imbalances require special caution. Additionally, patients who must restrict sodium intake should also exercise caution when using this medication. Various side effects can occur during the use of this medication. Allergic reactions such as skin rash, itching, and hives may occur, and if such symptoms appear, usage must be discontinued immediately. A range of side effects has been reported, including blood-related abnormalities, liver function issues, heart problems, gastrointestinal symptoms, neurological issues, respiratory problems, muscle pain, joint pain, skin problems, eye problems, and urinary system issues. If any of these symptoms occur, the patient should consult a healthcare professional to take appropriate measures. This medication suppresses gastric acid secretion, and long-term use may slightly increase the risk of gastrointestinal infections due to bacterial overgrowth in the stomach. In particular, if diarrhea persists, infection with Clostridium difficile should be suspected. This medication does not significantly affect the ability to drive or operate machinery; however, caution is advised as drowsiness may occur. This medication may interact with other drugs; thus, it is essential to consult healthcare professionals when taking it alongside warfarin, methotrexate, atazanavir, rilpivirine, etc. Pregnant or breastfeeding women should not take this medication, and those planning to conceive or who may be pregnant must consult a doctor. Elderly individuals face a higher risk of side effects due to decreased liver function; therefore, immediate consultation with a medical professional is necessary if symptoms occur. Safety for children has not been established, and there is insufficient experience in use, so caution should be exercised when administering to children. This medication should be swallowed whole and not chewed or crushed. When storing, keep out of reach of children and do not transfer to another container. Long-term use of this medication may lead to vitamin B12 absorption issues due to hypoacidity; thus, regular monitoring is necessary for prolonged use. If any unusual symptoms occur during use, the patient should inform healthcare professionals immediately for proper examination and treatment.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, heart block, palpitations, tachycardia, bradycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disturbance, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbance, tremors, weakness, neuroexcitation, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, weakness of limbs, sensory anesthesia, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccup, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthropathy, bursitis, muscle hypertonicity, neuralgia, isolated contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color change, toxic epidermal necrolysis, mucocutaneous syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacification, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, polyuria, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, elevated thyroid-stimulating hormone, bone fracture, gastric polyps, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus, halitosis, dry mouth, chest tightness, allergic reaction, hypertriglyceridemia, hypercholesterolemia, urticaria, facial edema, flushing, dizziness, tingling in hands and feet, palpitation, increased intraocular pressure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent air or moisture from entering. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the effectiveness of the medication.

Appearance and packaging

Appearance

Yellow-brown, egg-shaped film-coated tablets

Package unit

28 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.